PTEN and neoplasm: The effect of Pten loss is allele dose-dependent, with Pten−/− mESCs giving rise to large, undifferentiated tumours in vivo, whereas their heterozygous counterparts generate well-differentiated tumours composed of tissues from all three embryonic germ layers [53].